Virus specific IgG levels
TBEV
VIRUS
As part of the primary endpoint, TBEV and JEV specific IgG levels were measured before vaccination and at days 30 (30 days after dose 1) and 210 (30 days after dose 3) for the TBEV vaccine cohorts, and at days 30 (30 days after dose 1) and 60 (30 days after dose 2) for the JEV vaccine cohorts. Study participants with detectable virus nAbs at day 0 were excluded from ELISA and RFFIT analyses.Study participants from cohorts A1, A2, and C all developed IgG antibodies against TBEV by the end of the trial (